SCHEMBL6003765

SCHEMBL6003765

CC(C)(C)OC(=O)N1C[C@@H]2[C@H](C1)[C@]2(C#N)c1ccc(NC(=O)OCc2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.43
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
RCOR1 Q9UKL0 2/20 0.42
RORC P51449 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TGM2 P21980 5/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
POLB P06746 1/20 0.41
P2RX7 Q99572 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSK P43235 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29734806 0.86 MEN1 (0.40) P2RX7MEN1KMT2ACTSLCTSB
SCHEMBL5764315 0.85 NPC1 (0.43) RORCP2RX7MEN1KMT2ACTSL
SCHEMBL5790189 0.82 RORC (0.47) RORC
SCHEMBL30833571 0.82 RORC (0.47) RORC
SCHEMBL5790185 0.82 RORC (0.47) RORC
SCHEMBL5764459 0.80 KDM1A (0.51) KDM1AMAOAMAOBRCOR1TP53
SCHEMBL6002580 0.80 KDM1A (0.51) KDM1AMAOAMAOBRCOR1TP53
SCHEMBL2712652 0.79 KDM1A (0.44) KDM1AMAOAMAOBRCOR1RORC
SCHEMBL30833563 0.76 ABCB1 (0.44) RORCMAPTP2RX7MEN1KMT2A
SCHEMBL29778048 0.76 ABCB1 (0.44) RORCMAPTP2RX7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060247286-A1 Oxazolidinone antibiotics and derivatives thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247286-A1 Oxazolidinone antibiotics and derivatives thereof OXA1L, RORC, IL17A KDM1A 4357/4885MAOA 3244/4885MAOB 2243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.